Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003086 · ClinicalTrials.gov registry record · Phase 1
Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer
A Phase 1 study, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Terminated
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00003086 is a Phase 1 study that was terminated before completion, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 12 participants.
The verdict
NCT00003086, a Phase 1 study, was terminated before completion, sponsored by Louisiana State University Health Sciences Center Shreveport.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
RATIONALE: Bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of repeated use of high-dose chemotherapy plus bone marrow transplantation and samarium 153 in treating women who have stage IV breast cancer.
Interventions
- DRUG cisplatin
- DRUG carboplatin
- DRUG cyclophosphamide
- BIOLOGICAL filgrastim
- DRUG CAF regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 1997-03 |
| Est. Completion | 2001-01-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003086
The ClinicalTrials.gov registry entry for NCT00003086 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center Shreveport, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.
NCT00003086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003086 about?
NCT00003086 is a clinical study titled "Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer". RATIONALE: Bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of repeated use of high-dose chemotherapy plus bone marrow transplantation and samarium 153 in treating women who ha...
What is the current status of trial NCT00003086?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 1997-03. Estimated completion is 2001-01-28.
What interventions are being tested in trial NCT00003086?
The interventions under investigation include: cisplatin (DRUG), carboplatin (DRUG), cyclophosphamide (DRUG), filgrastim (BIOLOGICAL), CAF regimen (DRUG).
Who is sponsoring clinical trial NCT00003086?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.